ATP7A and neoplasm: This SFN-mediated reversal of resistance was due to upregulation of the tumor-suppressing miR-30a-3p, which subsequently targeted excision repair crosscomplementing1 (ERCC1) and ATPase copper transporting alpha (ATP7A), thereby amplifying drug uptake [112].